Multidrug resistance is still one the main problems for cancer treatment, since many chemotherapeutic agents are P-gp substrates and P-gp is overexpressed in cancer cells, hampering the internalization and leading to resistance to chemotherapeutic drugs; hence, recent research has focused on developing P-gp inhibitors [37]. The gene discussed is PGP; the disease is cancer.